Headshot of Steve Ramirez.

Steve Ramirez

Assistant professor of psychological and brain sciences
Boston University

Steve Ramirez is assistant professor of psychological and brain sciences at Boston University and a former junior fellow at Harvard University. He received his B.A. in neuroscience from Boston University and began researching learning and memory in Howard Eichenbaum’s lab. He went on to receive his Ph.D. in neuroscience in Susumu Tonegawa’s lab at the Massachusetts Institute of Technology, where his work focused on artificially modulating memories in the rodent brain. Ramirez’s current work focuses on imaging and manipulating memories to restore health in the brain.

Both in and out of the lab, Ramirez is an outspoken advocate for making neuroscience accessible to all. He is passionate about diversifying and magnifying the voices in our field through intentional mentorship—an approach for which he recently received a Chan-Zuckerberg Science Diversity Leadership Award. He has also received an NIH Director’s Transformative Research Award, the Smithsonian’s American Ingenuity Award and the National Geographic Society’s Emerging Explorer Award. He has been recognized on Forbes’ 30 under 30 list and MIT Technology Review‘s Top 35 Innovators Under 35 list, and he has given two TED Talks.

Explore more from The Transmitter

Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read

What counts as a ‘naturalistic’ behavior?

Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.

By Paul Middlebrooks
3 June 2026 | 1 min read
Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read